Drug development partnership
providing support for complete projects from the first laboratory-scale R&D trials to the production of validation batches.
Industrial manufacturing
which involves producing pharmaceutical products on a fee-for-service basis for national or international clients.
Licensing Opportunities
providing clients with the option to license already developed and market-ready products, enabling them to access the market more quickly than if they were developing the product themselves.
1980s
Creation of an R&D unit by Fournier Laboratories
1980s
1990s
Launch of a hormonal patch
Export and Marketing in the USA
1990s
2000s
Creation of the AdhexPharma company
Takeover of the Fournier Laboratories' patch research and production unit
2000s
2010s
New milestones
- 3 new productions launched and 4 marketing authorisations obtained
- Obtained ISO 13485 certification
2010s
2020s
We're growing!
- Aquisition of AMW transdermal assets
- Acquisition of Labtec, formerly known as "tesa Labtec"
2020s
Roland de la Brosse
Founder and President of the Adhex group since 2003
.png?width=200&height=250&name=Kopie%20von%20Design%20ohne%20Titel%20(1).png)
Anne Leclerq
Human Resources Director at AdhexPharma since March 2015
Alain Lambert
Site Director at AdhexPharma since August 2016
Anne-Laure Tedaldi
CMC Development Director at AdhexPharma since November 2015
Pascale Denis
Laboratory Director at AdhexPharma since March 2017
Bruno Loiseau
Managing Director at AdhexPharma since 2008
Patrick Amberg
Business Development Director at AdhexPharma since April 2018
Fabienne Robin
Quality Assurance Director and QP at AdhexPharma since 2014
